Abstract:The title compound, C12H9N2+center dot C7H4ClO3-center dot C12H8N2 center dot-C7H5ClO3, contains one phenanthrolinium (Hphen) cation, one phenanthroline (phen) molecule, one 4-chloro-2-hydroxybenzoate anion (hcba) and one 4-chloro-2-hydroxybenzoic acid (Hhcba) molecule in the asymmetric unit. The phen molecule is approximately parallel to Hphen, making a dihedral angle of 1.98 (6)degrees. The centroid-centroid distance between pyridine rings of adjacent phen and Hphen species is 3.7718 (15) angstrom, and that between the benzene and pyridine rings of adjacent phen and Hphen species is 3.7922 (16) angstrom, indicative of pi-pi stacking interactions. The crystal structure contains an extensive network of classical (O-H center dot center dot center dot O, N-H center dot center dot center dot N and O-H center dot center dot center dot Cl) and weak (C-H center dot center dot center dot O and C-H center dot center dot center dot N) hydrogen bonds. Finally, C-H center dot center dot center dot O interactions are seen between Hphen and hcba and between phen and Hhcba in the crystal structure. The hydroxy group of the anion is disordered over the two sites ortho to the carboxylate group in a 0.75: 0.25 ratio.

2-(<i>tert</i>-Butoxycarbonylamino)-6-(1,3-dioxo-1<i>H</i>-2,3-dihydrobenzo[<i>de</i>]isoquinolin-2-yl)hexanoic acid

2-( tert -Butoxycarbonylamino)-6-(1,3-dioxo-1 H -2,3-dihydrobenzo[ de ]isoquinolin-2-yl)hexanoic acid

1-Dehydroabietyl-4,5-diphenyl-1h-imidazole

N-(2,4-Dinitrophenyl)dehydroabietylamine

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

Hexakis(1H-imidazole-κN3)manganese(II) triaquatris(1H-imidazole-κN3)manganese(II) bis(naphthalene-1,4-dicarboxylate)

Hexakis(1H-imidazole-κN3)manganese(II) Triaquatris(1h-Imidazole-κn3)manganese(ii) Bis(naphthalene-1,4-dicarboxylate)

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

1,10-Phenanthrolinium 4-Chloro-2-hydroxybenzoate–1,10-phenanthroline–4-chloro-2-hydroxybenzoic Acid (1/1/1)

Hexakis(1H-imidazole-κN)nickel(II) Triaqua-Tris(1h-imidazole-κn)nickel(ii) Bis-(Naphthalene-1,4-dicarboxyl-ate).

Hexakis(1H-imidazole-κN3)nickel(II) triaquatris(1H-imidazole-κN3)nickel(II) bis(naphthalene-1,4-dicarboxylate)

Hexakis(1H-imidazole-κN3)cobalt(II) Triaquatris(1h-Imidazole-κn3)cobalt(ii) Bis(naphthalene-1,4-dicarboxylate)

Naphthalene-2,6-dicarboxylic acid&#8211;1-methylpyrrolidin-2-one (1/2)

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

2-(2-Chloro-phen-yl)-N-cyclo-hexyl-2-oxoacetamide.

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

rac-7-[(2E)-But-2-eno-yl]-13-chloro-N-cyclo-hexyl-7,8-dihydro-5H-isochromeno[4,3-c]phenanthridine-8-carboxamide.

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

N-Cyclohexyl-2-oxo-2-phenylacetamide